Acadia Pharmaceuticals Inc (ACAD) — 10-Q Filings

10-Q Filings (6)

• Acadia Pharma's Net Income Soars 42% on Strong Product Sales — Nov 6, 2025 Risk: medium
  ACADIA PHARMACEUTICALS INC. reported a significant increase in net income for the nine months ended September 30, 2025, reaching $117.432 million, up from $82.7
• Acadia Narrows Losses on Strong DAYBUE Sales, Revenue Jumps 15% — Aug 7, 2025 Risk: medium
  ACADIA PHARMACEUTICALS INC reported a significant increase in revenue for the three months ended June 30, 2025, reaching $148.9 million, up from $129.2 million
• Acadia Pharmaceuticals Files Q1 2025 10-Q — May 8, 2025 Risk: medium
  Acadia Pharmaceuticals Inc. filed its 10-Q for the period ending March 31, 2025. The filing details their financial performance and business operations. Key fin
• ACADIA Pharmaceuticals Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
  ACADIA Pharmaceuticals Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results and provided updates on its business
• ACADIA Pharmaceuticals Q2 2024 Update — Aug 7, 2024 Risk: medium
  ACADIA Pharmaceuticals Inc. reported its financial results for the quarter ended June 30, 2024. The company's filing details its financial position and operatio
• ACADIA Pharmaceuticals Inc. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: medium
  ACADIA PHARMACEUTICALS INC (ACAD) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. ACADIA Pharmaceuticals Inc. filed a 10-Q report for the period en

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX